Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CollPlant Biotechnologies Ltd. - Ordinary Shares
(NQ:
CLGN
)
0.5672
+0.0172 (+3.13%)
Streaming Delayed Price
Updated: 2:34 PM EST, Mar 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about CollPlant Biotechnologies Ltd. - Ordinary Shares
< Previous
1
2
Next >
CLGN Stock Crashed 14% Today – Disappointing Earnings, Workforce Reduction Plan Draws Investor Attention
↗
November 26, 2025
The firm reported revenue of $77,000 for the three months ended September, above the $4,000 reported in the corresponding quarter of 2024, but below an analyst estimate of $5.03 million, according to...
Via
Stocktwits
Topics
Artificial Intelligence
Workforce
CollPlant Biotechnologies Ltd (NASDAQ:CLGN) Plummets 10.7% on Q3 Earnings and Revenue Miss
↗
November 26, 2025
CollPlant stock plunges 10.7% after Q3 2025 earnings miss, with revenue of $80k far below the $4.94 million estimate.
Via
Chartmill
Topics
Earnings
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
August 21, 2025
Via
Benzinga
What's Next: CollPlant Biotechnologies's Earnings Preview
↗
August 19, 2025
Via
Benzinga
Earnings Preview: CollPlant Biotechnologies
↗
May 27, 2025
Via
Benzinga
CollPlant Biotechnologies's Earnings: A Preview
↗
November 26, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies
↗
August 21, 2024
Via
Benzinga
Analyst Expectations For CollPlant Biotechnologies's Future
↗
August 21, 2025
Via
Benzinga
CollPlant Biotechnologies Ltd (NASDAQ:CLGN) Q2 2025 Earnings Fall Significantly Short of Estimates
↗
August 20, 2025
CollPlant (CLGN) Q2 2025 results miss analyst estimates, with revenue of $180K far below expectations. Shares fell in pre-market trading on the earnings disappointment.
Via
Chartmill
Earnings Scheduled For August 20, 2025
↗
August 20, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 09, 2025
Via
Benzinga
Recap: CollPlant Biotechnologies Q3 Earnings
↗
November 29, 2023
Via
Benzinga
Dow Edges Higher; Dell Shares Fall After Q1 Results
↗
May 30, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 30, 2025
Via
Benzinga
Nasdaq Down 100 Points; Chicago PMI Dips In May
↗
May 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 30, 2025
Via
Benzinga
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
↗
May 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 28, 2025
Via
Benzinga
Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
May 28, 2025
Via
Benzinga
Earnings Scheduled For May 28, 2025
↗
May 28, 2025
Via
Benzinga
Earnings Scheduled For March 26, 2025
↗
March 26, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 27, 2024
Via
Benzinga
Earnings Scheduled For November 27, 2024
↗
November 27, 2024
Via
Benzinga
CLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024
↗
August 20, 2024
CLGN stock results show that CollPlant Biotechnologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
CLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024
↗
May 29, 2024
CLGN stock results show that CollPlant Biotechnologies met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023
↗
April 04, 2024
CLGN stock results show that CollPlant Biotechnologies missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For April 4, 2024
↗
April 04, 2024
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion.
Via
Benzinga
Earnings Scheduled For November 29, 2023
↗
November 29, 2023
Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per share on revenue of $3.50 million.
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
